ACLX

Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy

02/25 11:09 am

Halper Sadeh LLC is Investigating Whether ACLX, EHAB, VRE are Obtaining Fair Deals for their Shareholders

02/24 04:51 pm

Arcellx Surges as Gilead’s $7.8B Offer Locks In a 68% Premium

02/23 11:48 am

Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug

02/23 08:51 am

CAR T-Cell Therapy for Multiple Myeloma Market to Witness Upsurge in Growth by 2034 Owing to the Launch of Emerging Therapies | DelveInsight

10/08 01:00 pm

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

05/23 09:10 am

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

05/12 01:00 pm

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

03/05 02:00 pm

Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention

02/12 04:22 pm

Expert Ratings For Arcellx

05/31 08:01 am

Analyst Expectations For Arcellx's Future

05/14 08:01 am

Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates

05/09 05:10 pm

Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates

05/01 05:20 pm

How Arcellx (ACLX) Stock Stands Out in a Strong Industry

04/04 08:40 am

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley

03/07 03:52 pm

Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates

02/28 08:30 pm

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024

01/04 03:08 pm

Needham Maintains Buy Rating for Arcellx: Here's What You Need To Know

01/04 01:00 pm

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

12/20 11:33 am

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

12/12 02:22 pm

Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say

12/11 03:33 pm

Where Arcellx Stands With Analysts

12/11 08:00 am

Wall Street Breakfast: The Week Ahead

12/10 08:30 am

The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics

11/17 07:00 am

Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod

11/16 11:30 am

Arcellx (ACLX) Up 5% on Partnership Expansion With Gilead

11/16 11:10 am

Is a Surprise Coming for Arcellx (ACLX) This Earnings Season?

11/09 09:30 am

4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates

11/09 08:05 am

Roblox (RBLX) to Report Q3 Earnings: What's in the Cards?

11/06 03:36 pm

Take-Two (TTWO) to Report Q2 Earnings: What's in Store?

11/06 03:25 pm

What Awaits Warner Bros. Discovery (WBD) in Q3 Earnings?

11/06 12:40 pm

Disney (DIS) to Report Q4 Earnings: What's in the Cards?

11/06 12:38 pm

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023

10/17 11:00 am

Is Arcellx (ACLX) Stock Outpacing Its Medical Peers This Year?

10/17 09:40 am

Wall Street Analysts Believe Arcellx, Inc. (ACLX) Could Rally 35.56%: Here's is How to Trade

09/04 09:55 am

5 Biotech Stocks to Buy as New Drug Approvals Drive Industry Prospects

09/01 09:18 am

Gilead's (GILD) Leukemia Study Progress Put on Clinical Hold

08/22 11:47 am

Does Arcellx, Inc. (ACLX) Have the Potential to Rally 39.12% as Wall Street Analysts Expect?

08/17 09:55 am

Gilead (GILD), Tentarix To Develop Cancer, Inflammation Therapies

08/16 01:21 pm

Analysts Stay Bullish On Arcellx's CART-ddBCMA's Long-term Therapeutic Potential

08/15 02:42 pm

Gilead (GILD) Ends Myelodysplastic Syndromes Study on Magrolimab

07/24 10:44 am

Biotech Stock Roundup: DICE Gains on LLY Buyout, MRSN Down on Update & More

06/22 11:04 am

Arcellx (RCLX) Down on Hold for Lead Program CART-ddBCMA

06/21 10:38 am

Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

06/20 01:07 pm

Analyst Ratings for Arcellx

06/20 01:02 pm

Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

06/20 08:10 am

Alibaba, Arcellx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

06/20 06:39 am

The Latest Analyst Ratings for Arcellx

05/18 11:01 am

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023

05/18 11:00 am

Arcellx, Inc. (ACLX) Reports Q1 Loss, Misses Revenue Estimates

05/08 05:15 pm